JCB logo
PeproTech: Cell Culture Supplements
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.1795iti2
The Journal of Cell Biology, Vol. 179, No. 5, 807-
The Rockefeller University Press, 0021-9525 $30.00
© LeBrasseur
This Article
Right arrow Full Text (PDF, 913K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Peptidase frees receptors in endosomes



Figure 1
The recycling (top, arrowheads) of CLR (red) back to the plasma membrane is blocked in cells lacking ECE-1 (bottom).

Internalized pain receptors are freed up by a peptidase for another round of agony, Padilla et al. reveal.

Peptidases on the cell surface cleave and thereby activate or inactivate small, extracellular peptides such as angiotensin. The enzymes also reside in internal compartments called endosomes, where their action is less apparent.

The new work shows that a peptidase called ECE-1 needs the low pH of the endosome to cleave several of its targets. One such peptide target was CGRP, which is released by cells during inflammation. Binding of CGRP to its receptor, CLR, induces pain signaling pathways in neurons. The peptide–receptor complex is then internalized into endosomes, which switches off the pain pathway.

Padilla and colleagues found that the internalized peptide/receptor was accompanied by ECE-1 into endosomes. There, the low pH encouraged the peptide to fall off its receptor. Cleavage by ECE-1 helped to ensure that the peptide did not rebind.

The dissolution of the pair released an associated scaffolding protein called β-arrestin, whose liberation allowed the receptor to return to the cell surface. This ECE-1–induced recycling was necessary for cells to respond to a second round of CGRP. Inhibitors of ECE-1, which were developed to block activation of a peptide that raises blood pressure, might thus have analgesic and antiinflammatory effects. Formula

Reference:

Padilla, B.E., et al. 2007. J. Cell Biol. 179:981–997.[Abstract/Free Full Text]



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 913K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents